Apellis announces 24-month phase 3 post hoc results demonstrating treatment…

Recent analyzes of microperimetry data showed positive trends for both monthly and bimonthly Pegcetacoplan treatment near the GA lesion margin compared to sham treatment These analyzes provide further evidence that slowing the growth of GA lesions with Pegcetacoplan has the potential to preserve visual function The data were presented during an oral presentation at the […]